Should transesophageal echocardiography be done in all patients who underwent catheter ablation of atrial fibrillation? A case report and review of the literature

Frühauf, Manuela; Eitel, Charlotte; Bollmann, Andreas; Piorkowski, Christopher; Wetzel, Ulrike; Schliephake, Florian; Arya, Arash

doi:10.1007/s00392-009-0091-4

Cited by 3 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A TEE should be performed for patients who do not receive appropriate systemic anticoagulants for 3 weeks or for whom the duration of treatment is uncertain before the intervention [259]. Several studies suggested that even adequate anticoagulation could not exclude the possibility of the presence of left atrial thrombi or sludge in the LAA [260–262]. TEE can be performed on the day of, or up to 24 h before, the ablation to rule out the presence of atrial thrombi.…”

Section: Practical Use Of Noacsmentioning

confidence: 99%

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

Chiang

Okumura

Zhang

et al. 2017

Journal of Arrhythmia

155

193

View full text Add to dashboard Cite

Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF-associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF-associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non-vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub-committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub-committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.

show abstract

Section: Practical Use Of Noacsmentioning

confidence: 99%

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

Chiang

Okumura

Zhang

et al. 2017

Journal of Arrhythmia

155

193

View full text Add to dashboard Cite

show abstract

“…Use of preablation TEE varies from use in all patients [19][20][21][22][23][24], to no routine preablation TEE [8,[25][26][27][28][29][30]. Use of preablation TEE varies from use in all patients [19][20][21][22][23][24], to no routine preablation TEE [8,[25][26][27][28][29][30].…”

Section: Thromboembolic Risk During Atrial Fibrillation Ablationmentioning

confidence: 99%

The use of anticoagulation during the periprocedure period of atrial fibrillation ablation

Tsang

2012

Current Opinion in Cardiology

View full text Add to dashboard Cite

The use of atrial fibrillation ablation has increased over the past decade. Along with technique and technology advances that have improved the success of ablation, strides have been made in minimizing thromboembolic and bleeding risks and in the availability of a broader choice of anticoagulants. Research is ongoing to identify patients most suitable for ablation and to determine the long-term efficacy and safety of this treatment option.

show abstract

CHADS2 and CHA2DS2-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus

et al. 2012

View full text Add to dashboard Cite

In an unselected TEE population with newly detected LA thrombus about one-third of patients fell into the low-risk group when classified based on the CHADS(2) score, while a much lower population fell in the same low-risk group when classified according to the CHA(2)DS(2)-VASc score. However, this does not prove clinical superiority of the CHA(2)DS(2)-VASc score over the established CHADS(2) score. Whether our observation has clinical implications (e.g. TEE prior to LA ablation irrespective of CHADS(2) score), or argues for use of the CHA(2)DS(2)-VASc score needs to be evaluated in prospective studies.

show abstract

Should transesophageal echocardiography be done in all patients who underwent catheter ablation of atrial fibrillation? A case report and review of the literature

Cited by 3 publications

References 17 publications

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

The use of anticoagulation during the periprocedure period of atrial fibrillation ablation

CHADS2 and CHA2DS2-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus

Contact Info

Product

Resources

About